Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

EU secures up to 2 million monkeypox vaccine doses from Bavarian Nordic

Published 17/11/2022, 17:13
© Reuters. FILE PHOTO: A woman holds a mock-up vial labeled "Monkeypox vaccine" and medical syringe in this illustration taken, May 25, 2022. REUTERS/Dado Ruvic/Illustration

(Reuters) -The European Union said on Thursday it had secured supply of up to 2 million doses of a monkeypox vaccine from Danish company Bavarian Nordic for the next two years.

The joint procurement will allow 14 countries, including EU member states, western Balkan countries and those in the European Economic Area to purchase the vaccine.

About 700,000 doses are expected to be delivered in 2023.

Around 80,000 cases of monkeypox have been reported in about 100 countries since the outbreak started earlier this year.

World Health Organization continues to classify the disease as a public health emergency of international concern, which is its highest level of alert.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.